Norges Bank’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-131,300
| Closed | -$1.55M | – | 886 |
|
|
2024
Q2 | $1.55M | Buy |
+131,300
| New | +$1.55M | ﹤0.01% | 1765 |
|
|
2023
Q1 | – | Sell |
-218,900
| Closed | -$1.48M | – | 2128 |
|
|
2022
Q4 | $1.48M | Buy |
218,900
+204,000
| +1,369% | +$1.38M | ﹤0.01% | 2009 |
|
|
2022
Q3 | $216K | Hold |
14,900
| – | – | ﹤0.01% | 2075 |
|
|
2022
Q2 | $147K | Buy |
+14,900
| New | +$147K | ﹤0.01% | 2044 |
|
|
2020
Q4 | – | Sell |
-21,400
| Closed | -$269K | – | 2138 |
|
|
2020
Q3 | $269K | Sell |
21,400
-72,000
| -77% | -$905K | ﹤0.01% | 2109 |
|
|
2020
Q2 | $1.13M | Buy |
+93,400
| New | +$1.13M | ﹤0.01% | 2003 |
|